Where Does Horizon Therapeutics PLC (HZNP) Stock Fall in the Drug Manufacturers - General Field?

Friday, September 25, 2020 8:14 AM | InvestorsObserver Analysts

(HZNP) leads the Drug Manufacturers - General industry with an overall score of 92. HZNP is up 173.83% so far this year after the company closed yesterday at $75.33. The overall score measures the company's performance based-off both short and long term indicators and means that HZNP scores better than 92% of the overall market.

Overall Score - 92
HZNP has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on HZNP!

Horizon Therapeutics PLC is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 52. This means that, on average, the stocks in this industry score higher than 52% of the stock market.

To see InvestorsObserver's Sentiment Score for Horizon Therapeutics PLC click here.

HZNP stock is trading down -3.37% this week following yesterday's rise. HZNP has an average analyst ranking of Strong Buy with an average price target of $104.444.

Click Here to get the full Stock Score Report on Horizon Therapeutics PLC (HZNP) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like